Role of OX40 expression on CD4+T lymphocytes as marker of disease activity in systemic lupus erythematosus / Aya Erfan Mostafa Seri ; Supervised Reem Jan Farid , Nermine Magdi Riad , Rasha Mahmoud Elrefai
Material type:
- كمؤشر لنشاط الذئبة الحمراءCDالمساعفة٤Tدور التعبير الخلوى المناعى للأوكس ٤٠على الخلايا اللمفاوية نوع [Added title page title]
- Issued also as CD
Item type | Current library | Home library | Call number | Copy number | Status | Barcode | |
---|---|---|---|---|---|---|---|
![]() |
قاعة الرسائل الجامعية - الدور الاول | المكتبة المركزبة الجديدة - جامعة القاهرة | Cai01.11.07.M.Sc.2015.Ay.R (Browse shelf(Opens below)) | Not for loan | 01010110066941000 | ||
![]() |
مخـــزن الرســائل الجـــامعية - البدروم | المكتبة المركزبة الجديدة - جامعة القاهرة | Cai01.11.07.M.Sc.2015.Ay.R (Browse shelf(Opens below)) | 66941.CD | Not for loan | 01020110066941000 |
Browsing المكتبة المركزبة الجديدة - جامعة القاهرة shelves Close shelf browser (Hides shelf browser)
Thesis (M.Sc.) - Cairo University - Faculty of Medicine- Department of in Clinical and Chemical Pathology
Background Systemic lupus erythematosus (SLE) is a chronic autoimmune disease characterized by production of autoantibodies & formation of immune complex. The hallmark of SLE is the production of autoantibodies. They are produced by autoreactive B cell due to loss of tolerance to self antigens and aberrant T cell regulation which leads to autoimmunity. Abnormally increased expression of OX40 and OX40Ligand (OX40L) is a major reason for the activation of T-cells in SLE. Aim of the study The current study aimed to find out the role of OX40 and OX40L in the pathogenesis of SLE and lupus nephritis (LN) and to correlate them with disease activity. Material and Methods Determination of percentage of CD4+ T-lymphocytes expressing OX40 (CD134) by flowcytometry and measurement of OX40L serum level by Enzyme Linked Immunosorbent Assay (ELISA) in 50 SLE patients divided into 2 groups (25 lupus nephritis, 25 non nephritis) and 20 healthy controls of matched age and gender
Issued also as CD
There are no comments on this title.